J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
Helicobacter pylori therapy: first-line options and rescue regimen.
TL;DR: All different proton pump inhibitors (PPIs) are equivalent when prescribed with antibiotics, and ranitidine bismuth citrate is equal to or, in some cases with antibiotic resistance, more effective than PPI.
Journal ArticleDOI
Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long‐term, follow‐up study of 394 patients
TL;DR: This data indicates that the use of thiopurinic drugs in Crohn’s disease, and particularly in ulcerative colitis, is safe and effective and should be considered as a routine treatment for CD.
Journal ArticleDOI
Impact of current smoking on the clinical course of microscopic colitis.
Fernando Fernández-Bañares,Monia R. de Sousa,Antonio Salas,Belén Beltrán,M Piqueras,Eva Iglesias,Javier P. Gisbert,Beatriz Lobo,Valentí Puig-Diví,Esther Garcia-Planella,Ingrid Ordás,Montserrat Andreu,Marta Calvo,Miguel Montoro,Maria Esteve,Josep Maria Viver +15 more
TL;DR: Active smokers developed MC more than a decade before nonsmokers, and age at diagnosis, but not smoking, was an independent risk factor of relapse in patients with CC.
Journal ArticleDOI
IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
Javier P. Gisbert,Javier Molina-Infante,Javier Amador,Fernando Bermejo,Luis Bujanda,Xavier Calvet,Manuel Castro-Fernandez,Antonio Cuadrado-Lavín,J. Ignasi Elizalde,Emili Gené,Fernando Gomollón,Angel Lanas,Carlos Martín de Argila,Fermín Mearin,Miguel Montoro,Ángeles Pérez-Aisa,Emilio Pérez-Trallero,Adrian G. McNicholl +17 more
TL;DR: Only quadruple therapies (with or without bismuth), and generally lasting 14 days, are recommended both for first and second line treatments, in the present consensus on H.pylori infection.
Journal ArticleDOI
Should we monitor vitamin B12 and folate levels in Crohn's disease patients?
Fernando Bermejo,Alicia Algaba,Iván Guerra,María Chaparro,Gema de-la-Poza,Paz Valer,B. Piqueras,Andrea Bermejo,Javier García-Alonso,María-José Pérez,Javier P. Gisbert +10 more
TL;DR: A significant proportion of patients with Crohn's disease suffer from vitamin B12 and/or folate deficiency, suggesting that regular screening should be performed, with closer monitoring in patients with ileal resection or active disease.